Related Experiment Video

Updated: May 25, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.6K

Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint

Connor Frey1

  • 1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|February 26, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
immune checkpoint inhibitorsimmune-related adverse eventsimmunotherapyirAEpharmacovigilance

More Related Videos

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
66.7K